. Author manuscript; available in PMC: 2021 Jun 1.

Published in final edited form as: Contemp Clin Trials. 2020 Apr 17;93:106007. doi: 10.1016/j.cct.2020.106007

Table 3.

Data Sources and their corresponding role in study analyses

Source	Study Domain	Data Variables	Data Collection
EHRs	Covariates	Race/ethnicity, age, insurance status, comorbid conditions, cancer stage	Automated extraction of discrete EHR fields
EHRs	Effectiveness (outcomes)	Time to treatment (# days) Guideline-concordant treatment (yes/no)	Manual abstraction using standardized form
Registry	Implementation	Fidelity to navigation protocol. e.g. completed intake, communicated with other navigators	Aggregate reports from REDCap platform
SDOH Platform	Implementation	Fidelity to protocol. e.g. completed systematic screen at baseline and 3 months y/n	Aggregate reports from SDOH Screening platform
Navigator Interviews	Implementation	Acceptability, Adoption/Penetration	Transcripts from one on one structured interviews with TRIP Navigators
Navigator Observations	Implementation	Fidelity, Adoption/Penetration	Field observations of TRIP navigators in the clinical setting
Focus Groups	Implementation	Acceptability, Adoption/penetration, Sustainability	Transcripts from focus groups with hospital administrators and clinicians
Surveys	Implementation	Cost	Survey (study personnel) of costs associated with developing and implementing training, registry and SDOH screening platform; Survey of time spent on TRIP related activities (navigators and supervisor)